Testimonials
Billionaires including Elon Musk and Michael Rubin of Fanatics have sung the praises of GLP-1 drugs including Wegovy and Ozempic for weight loss. Here are a few resources to understand the trends and what manage care pharmacists need to know.
It’s crucial that MCPs are armed with the tools they need to ensure patients get the medications they need at a cost they can afford—and that starts with you.
AMCP 2024 AAO Report
AMCP's feature annual report explores how professionals in managed care pharmacy work diligently to facilitate appropriate access to prescription treatments while remaining mindful of rising costs. It discusses key areas of focus such as pharmacy benefit design, formulary management, clinical programs, quality, safety and promoting affordability of medicines.
AMCP eModel is the ultimate tool for communication of health economic models and value evidence. Find out more about this tech partnership and this health economic modeling platform to support the exchange of clinical and economic information between manufacturers and payers.
AMCP partners with FormularyDecisions to enhance information sharing and formulary decision-making by creating a platform for current, credible, and compliant information exchange between life science companies and active, qualified healthcare decision-makers.
Meetings Proceedings & Findings
AMCP CEO Blog: With PA so often misunderstood, perhaps we need to do a better job of explaining this tool to the general public. For example, we might provide an example of how PAs are applied to opioids as additional safeguards to ensure their appropriate use. Or how a PA might be applied to botulinum toxin to ensure the prescription is for medical, rather than cosmetic, purposes.
A retrospective claims analysis in JMCP found that patients who received an outpatient opioid prescription following surgery had significantly increased health care utilization and costs for the following year.
A retrospective claims analysis in JMCP found that patients who received an outpatient opioid prescription following surgery had significantly increased health care utilization and costs for the following year.
From the AMCP Policy Digest, AMCP's policies regarding generics programs.
From the AMCP Policy Digest, AMCP's policies regarding supply chain management.
From the AMCP Policy Digest, AMCP's policies regarding drug naming issues.
From the AMCP Policy Digest, AMCP's policies regarding patient confidentiality.
From the AMCP Policy Digest, AMCP's policies regarding health information and automation technology.
From the AMCP Policy Digest, AMCP's policies regarding workforce issues.
From the AMCP Policy Digest, AMCP's policies regarding drug integrity issues.
From the AMCP Policy Digest, AMCP's policies regarding pharmacy practice issues.
From the AMCP Policy Digest, AMCP's policies regarding managed care pharmacy tools.
